SARAH BOWERS: Open Payments
NPI 1932632510 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$285 in 13 payments from 11 companies in 2025. Trend: 2023 $2,041 · 2024 $2,832 · 2025 $285
Food & beverage: $285
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $58 |
| Organon LLC | 2 | $45 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| Incyte Corporation | 1 | $24 |
| ABBVIE INC. | 1 | $22 |
| Almirall LLC | 1 | $21 |
| Galderma Laboratories, L.P. | 1 | $21 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $17 |
Products named: DUPIXENT, YCANTH, OPZELURA, RINVOQ, Klisyri, AKLIEF, ILUMYA, SILIQ.
Industry payments across PA — which companies pay providers there.
